基于生理学的药理动力学和人口药理动力学模型的概述:用于分析和个性化放射性药物治疗的应用
Deni Hardiansyah1, Bisma Barron Patrianesha2, Kuangyu Shi3
1Medical Physics and Biophysics Research Group, Department of Physics, Faculty of Mathematics and Natural Sciences (FMIPA), Universitas Indonesia, Indonesia.
基于生理学的药理动力学 (PBPK) 和人口药理动力学 (PopPK) 模型为放射性药物治疗 (RPT) 剂量提供了优势. 这些模型旨在通过提高治疗结果的精度和安全性来改进个性化的RPT.
科学领域:
- 药理动力学 药理动力学
- 放射性药物疗法是一种放射性药物疗法.
- 数学建模的数学建模
背景情况:
- 放射性药物治疗 (RPT) 依赖于准确的剂量测量来确定疗效和安全性.
- 基于生理学的药理动力学 (PBPK) 和人口药理动力学 (PopPK) 模型是RPT的新兴工具.
- 了解这些模型的应用,好处和缺点对于临床翻译至关重要.
研究的目的:
- 审查PBPK和PopPK模型在RPT中的当前应用.
- 讨论这些建模方法的优点和局限性.
- 探索未来优化RPT剂量策略的方向.
主要方法:
- 在RPT中对PBPK和PopPK模型应用的文献综述.
- 分析模型与生理和人口数据的整合.
- 讨论潜在的进步和挑战.
主要成果:
- PBPK模型使用生理和药物参数模拟放射性药物动力学.
- PopPK模型通过使用人口数据来提高个人剂量估计.
- 这两种模型都显示出提高RPT精度和安全性的潜力.
结论:
- PBPK和PopPK模型对于个性化的RPT剂量是有价值的.
- 未来的工作应该专注于混合模型,人工智能集成和监管框架.
- 广泛采用这些建模策略可以改善治疗结果和患者安全.
更多相关视频
09:55Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
Published on: October 4, 2024
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
相关概念视频
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model Approaches for Pharmacokinetic Data: Physiological Models
Dosage Regimens: Partial Pharmacokinetic Parameters
